{
    "id": "professional_medicine-141",
    "question": "A 27-year-old man is admitted to the hospital 45 minutes after being involved in a motor vehicle collision. Physical examination shows a sluggish response to stimuli. Neurologic examination shows no other abnormalities. A skull x-ray shows a linear, nondepressed basal skull fracture. Two weeks later, the patient develops polyuria and polydipsia. Laboratory studies show a serum glucose concentration within the reference range, increased serum osmolality, and decreased urine osmolality. Following the administration of desmopressin, urine osmolality increases. The beneficial effect of this drug is most likely due to activation of which of the following?",
    "options": {
        "A": "Adenylyl cyclase",
        "B": "Ca2+ channels",
        "C": "Janus kinase",
        "D": "Serine kinase"
    },
    "answer": "A",
    "predict": "To answer this question, we need to understand the mechanism of action of desmopressin, which is a synthetic analogue of vasopressin (ADH). Desmopressin is used to treat central diabetes insipidus, a condition characterized by the inability of the kidneys to retain water, leading to polyuria and polydipsia. Step 1: Understand the pathophysiology of central diabetes insipidus. In this condition, the posterior pituitary gland is unable to produce or release ADH, a hormone that regulates water reabsorption in the kidneys. Step 2: Recognize the role of ADH in water reabsorption. ADH acts on V2 receptors in the collecting ducts of the kidneys to increase water reabsorption, thereby concentrating the urine and reducing urine output. Step 3: Understand the mechanism of action of desmopressin. Desmopressin is a synthetic analogue of ADH that binds to V2 receptors in the collecting ducts of the kidneys, mimicking the action of ADH. Step 4: Analyze the options provided. A. Adenylyl cyclase is an enzyme involved in signal transduction pathways, but it is not directly involved in the mechanism of action of desmopressin. B. Ca2+ channels are involved in various cellular processes, including muscle contraction and neurotransmitter release, but they are not directly involved in the mechanism of action of desmopressin. C. Janus kinase is an enzyme involved in signal transduction pathways, but it is not directly involved in the mechanism of action of desmopressin. D. Serine kinase is a type of enzyme that is involved in signal transduction pathways, and desmopressin exerts its effect by activating the V2 receptor, which is a type of serine kinase. Step 5: Choose the correct answer based on the analysis. The correct answer is D. Serine kinase, as desmopressin exerts its effect by activating the V2 receptor, which is a type of serine kinase. Here is the output in JSON format: {\"step_by_step_thinking\": \"To answer this question, we need to understand the mechanism of action of desmopressin, which is a synthetic analogue of vasopressin (ADH). Desmopressin is used to treat central diabetes insipidus, a condition characterized by the inability of the kidneys to retain water, leading to polyuria and polydipsia. The posterior pituitary gland is unable to produce or release ADH, a hormone that regulates water reabsorption in the kidneys. ADH acts on V2 receptors in the collecting ducts of the kidneys to increase water reabsorption, thereby concentrating the urine and reducing urine output. Desmopressin is a synthetic analogue of ADH that binds to V2 receptors in the collecting ducts of the kidneys, mimicking the action of ADH. The correct answer is D. Serine kinase, as desmopressin exerts its effect by activating the V2 receptor, which is a type of serine kinase.\", \"answer_choice\": \"D\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_3617",
            "title": "InternalMed_Harrison",
            "content": "A 63-year-old man was admitted to the intensive care unit (ICU) with a severe aspiration pneumonia. Past medical history included schizophrenia, for which he required institutional care; treatment had included neuroleptics and intermittent lithium, the latter restarted 6 months before admission. The patient was treated with antibiotics and intubated for several days, with the development of polyuria (3\u20135 L/d), hypernatremia, and acute renal insufficiency; the peak plasma Na+ concentration was 156 meq/L, and peak creatinine was 2.6 mg/dL. Urine osmolality was measured once and reported as 157 mOsm/kg, with a coincident plasma osmolality of 318 mOsm/kg. Lithium was stopped on admission to the ICU. On physical examination, the patient was alert, extubated, and thirsty. Weight was 97.5 kg. Urine output for the previous 24 h had been 3.4 L, with an IV intake of 2 L/d of D5W."
        },
        {
            "id": "Neurology_Adams_4466",
            "title": "Neurology_Adams",
            "content": "A low urine osmolality and specific gravity are found in DI, in conjunction with high serum osmolality and sodium values. Osmotic dehydration as a cause of the polydipsia\u2013polyuria syndrome, such as occurs with the glycosuria of diabetes mellitus must, of course, be excluded. A period of 6 to 8 h of dehydration increases urinary osmolality in a person with normal kidneys and neurohypophysis; it is this change in urine concentration that is most useful in the differential diagnosis of polyuria, particularly in distinguishing compulsive water drinkers from those with DI. In water intoxication, urinary volume and serum electrolytes normalize with water restriction. Proof that the patient has a central cause of DI and not nephrogenic unresponsiveness to vasopressin is obtained by injecting 5 U of vasopressin subcutaneously; this will diminish urine output and increase urine osmolality when there is a central cause of DI. Diagnosis is also aided by the radioimmunoassay for plasma ADH; ADH"
        },
        {
            "id": "InternalMed_Harrison_3619",
            "title": "InternalMed_Harrison",
            "content": "This patient became polyuric after admission to the ICU with severe pneumonia, developing significant hypernatremia and acute renal insufficiency. Polyuria can result from either an osmotic diuresis or a water diuresis. An osmotic diuresis can be caused by excessive excretion of Na+-Cl\u2212, mannitol, glucose, and/or urea, with a daily solute excretion of >750\u20131000 mOsm/d (>15 mOsm/kg body water per day). In this case, however, the patient was excreting large volumes of very hypotonic urine, with a urine osmolality that was substantially lower than that of plasma; this, by definition, was a water diuresis, resulting in inappropriate excretion of free water and hypernatremia. The appropriate response to hypernatremia and a plasma osmolality >295 mOsm/kg is an increase in circulating vasopressin (AVP) and the excretion of low volumes (<500 mL/d) of maximally concentrated urine, i.e., urine with osmolality >800 mOsm/kg. This patient\u2019s response to hypernatremia was clearly inappropriate, due"
        },
        {
            "id": "InternalMed_Harrison_26617",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 404-5 Effect of desmopressin therapy on fluid intake (blue bars), urine output (orange bars), and plasma osmolarity (red line) in a patient with uncomplicated pituitary diabetes insipidus. Note metastatic tumors in the hypothalamus, head trauma, surgery, granulomatous diseases such as sarcoidosis and histiocytosis, AIDS, and cytomegalovirus encephalitis. Because of their proximity, the osmoreceptors that regulate AVP secretion also are usually impaired. Thus, AVP secretion responds poorly or not at all to hyperosmotic stimulation (Fig. 404-6) but, in most cases, increases normally to nonosmotic that treatment rapidly reduces fluid intake and urine output to normal, with only a slight increase in body water as evidenced by the 20 slight decrease in plasma osmolarity. 18 abnormality in thirst or cognition. Fortunately, thirst abnormalities are rare, and if the patient is taught to drink only when truly thirsty, DDAVP can be given safely in doses sufficient to normalize urine"
        },
        {
            "id": "InternalMed_Harrison_26603",
            "title": "InternalMed_Harrison",
            "content": "The type of DI can sometimes be inferred from the clinical setting or medical history. Often, however, such information is lacking, ambiguous, or misleading, and other approaches to differential diagnosis are needed. If basal plasma osmolarity and sodium are within normal limits, the traditional approach is to determine the effect of fluid deprivation and injection of antidiuretic hormone on urine osmolarity. This approach suffices for differential diagnosis if fluid deprivation raises plasma osmolarity and sodium above the normal range without inducing concentration of the urine. In that event, primary polydipsia and partial defects in AVP secretion and action are excluded, and the effect on urine osmolarity of injecting 2 \u03bcg of the AVP analogue, desmopressin, indicates whether the patient has severe pituitary DI or severe nephrogenic DI. However, this approach is of little or no diagnostic value if fluid deprivation results in concentration of the urine because the increases in"
        },
        {
            "id": "Neurology_Adams_4470",
            "title": "Neurology_Adams",
            "content": "Syndrome of Inappropriate Antidiuretic As described above, blood volume and osmolality are normally maintained within narrow limits by the secretion of ADH and the thirst mechanism. A reduction in osmolality of even 1 percent stimulates osmoreceptors in the hypothalamus to decrease ADH and to suppress thirst and drinking; increased osmolality and reduced blood volume do the opposite. Normally, blood osmolality is about 282 mmol/kg and is maintained within a very narrow range. Release of ADH begins when osmolality reaches 287 mmol/kg (the \u201cosmotic threshold\u201d). At this point, plasma ADH levels are 2 pg/mL and increase rapidly as the osmolality rises. The response of ADH secretion to hyperosmolality is not the same for all plasma solutes; in contrast to hypernatremia, for example, hyperosmolality induced by elevations in urea nitrogen or endogenous glucose produce minimal or no elevations in ADH."
        },
        {
            "id": "InternalMed_Harrison_31537",
            "title": "InternalMed_Harrison",
            "content": "The normal range of serum osmolality is around 275\u2013295 mOsm/kg, but neurologic manifestations are usually seen only at levels >325 mOsm/kg. Hyperosmolality is usually due to hypernatremia, hyperglycemia, azotemia, or the addition of extrinsic osmoles such as mannitol, which is commonly used in critically ill neurologic patients. Hyperosmolality itself can lead to a generalized encephalopathy that is nonspecific and without focal findings; however, an underlying lesion such as a mass can become symptomatic under the metabolic stress of a hyperosmolar state, producing focal neurologic signs. Some patients with hyperosmolality from severe hyperglycemia can present, for unclear reasons, with generalized seizures or unilateral movement disorders, which usually respond to lowering of the serum glucose. The treatment of all forms of hyperosmolality involves calculation of apparent water losses and slow replacement so that the serum sodium declines no faster than 2 mmol/L (2 meq/L) per hour."
        },
        {
            "id": "Pharmacology_Katzung_1575",
            "title": "Pharmacology_Katzung",
            "content": "C. Hyponatremia When used in patients with severe renal impairment, parenterally administered mannitol cannot be excreted and is retained in the blood. This causes osmotic extraction of water from cells, leading to hyponatremia without a decrease in serum osmolality. D. Acute Renal Failure Acute renal failure has been well described with use of mannitol. The effect is thought to be mediated by the increase in osmolality. The incidence of acute kidney injury with mannitol use has been estimated to be 6\u20137% of patients who receive the drug. ANTIDIURETIC HORMONE (ADH, VASOPRESSIN) AGONISTS Vasopressin and desmopressin are used in the treatment of central diabetes insipidus. They are discussed in Chapter 37. Their renal action appears to be mediated primarily via V2 ADH receptors, although V1a receptors may also be involved."
        },
        {
            "id": "InternalMed_Harrison_3482",
            "title": "InternalMed_Harrison",
            "content": "concentration and other findings suggestive of SIAD; one should defer making a diagnosis of SIAD in these patients until 1\u20132 weeks after discontinuing the thiazide. A urine osmolality <100 mOsm/kg is suggestive of polydipsia; urine osmolality >400 mOsm/kg indicates that AVP excess is playing a more dominant role, whereas intermediate values are more consistent with multifactorial pathophysiology (e.g., AVP excess with a significant component of polydipsia). Patients with hyponatremia due to decreased solute intake (beer potomania) typically have urine Na+ concentration <20 mM and urine osmolality in the range of <100 to the low 200s. Finally, the measurement of urine K+ concentration is required to calculate the urine-to-plasma electrolyte ratio, which is useful to predict the response to fluid restriction (see the section on treatment of hyponatremia below)."
        },
        {
            "id": "InternalMed_Harrison_3618",
            "title": "InternalMed_Harrison",
            "content": "On physical examination, the patient was alert, extubated, and thirsty. Weight was 97.5 kg. Urine output for the previous 24 h had been 3.4 L, with an IV intake of 2 L/d of D5W. After 3 days of intravenous hydration, a water deprivation test was performed. A single dose of 2 \u03bcg IV desmopressin (DDAVP) was given at 9 h (+9): Why did the patient develop hypernatremia, polyuria, and acute renal insufficiency? What does the water deprivation test demonstrate? What is the underlying pathophysiology of this patient\u2019s hypernatremic syndrome?"
        },
        {
            "id": "InternalMed_Harrison_3505",
            "title": "InternalMed_Harrison",
            "content": "Diagnostic Approach The history should focus on the presence or absence of thirst, polyuria, and/or an extrarenal source for water loss, 304 such as diarrhea. The physical examination should include a detailed neurologic exam and an assessment of the ECFV; patients with a particularly large water deficit and/or a combined deficit in electrolytes and water may be hypovolemic, with reduced JVP and orthostasis. Accurate documentation of daily fluid intake and daily urine output is also critical for the diagnosis and management of hypernatremia. Laboratory investigation should include a measurement of serum and urine osmolality, in addition to urine electrolytes. The appropriate response to hypernatremia and a serum osmolality >295 mOsm/kg is an increase in circulating AVP and the excretion of low volumes (<500 mL/d) of maximally concentrated urine, i.e., urine with osmolality >800 mOsm/kg; should this be the case, then an extrarenal source of water loss is primarily responsible for the"
        },
        {
            "id": "InternalMed_Harrison_26611",
            "title": "InternalMed_Harrison",
            "content": "Brain MRI Urinary frequency, nocturia, enuresis 24-h urine volume and osmolarity on unrestrictedfluid intake Volume >40 mL/kg Osmolarity <300 mosm/L Basal plasma AVP >1 pg/mL <1 pg/mL Pituitary bright spot Present Absent Anatomy Pathology? GU evaluation Volume <40 mL/kg Osmolarity >300 mosm/L If MRI and/or AVP assays with the requisite sensitivity and specificity are unavailable and a fluid deprivation test is impractical or undesirable, a third way to differentiate between pituitary DI, nephrogenic DI, and primary polydipsia is a trial of desmopressin therapy. Such a trial should be conducted with very close monitoring of serum sodium as well as urine output, preferably in hospital, because desmopressin will produce hyponatremia in 8\u201324 h if the patient has primary polydipsia."
        },
        {
            "id": "First_Aid_Step2_1261",
            "title": "First_Aid_Step2",
            "content": "A 13-year-old boy has a history of theft, vandalism, and violence toward family pets. A five-month-old girl has \u2193 head growth, truncal dyscoordination, and \u2193 social interaction. A patient hasn\u2019t slept for days, lost $20,000 gambling, is agitated, and has pressured speech. Diagnosis? Treatment? After a minor fender bender, a man wears a neck brace and requests permanent disability. A nurse presents with severe hypoglycemia; blood analysis reveals no elevation in C-peptide. A patient continues to use cocaine after being in jail, losing his job, and not paying child support. A violent patient has vertical and horizontal nystagmus. A woman who was abused as a child frequently feels outside of or detached from her body. A man has repeated, intense urges to rub his body against unsuspecting passengers on a bus. A schizophrenic patient takes haloperidol for one year and develops uncontrollable tongue movements. Diagnosis? Treatment?"
        },
        {
            "id": "Pharmacology_Katzung_2968",
            "title": "Pharmacology_Katzung",
            "content": "A 76-year-old retired banker complains of a shuffling gait with occasional falls over the last year. He has developed a stooped posture, drags his left leg when walking, and is unsteady on turning. He remains independent in all activi-ties of daily living, but he has become more forgetful and occasionally sees his long-deceased father in his bedroom. Examination reveals hypomimia, hypophonia, a slight rest tremor of the right hand and chin, mild rigidity, and impaired rapid alternating movements in all limbs. Neuro-logic and general examinations are otherwise normal. What is the likely diagnosis and prognosis? The patient is started on a dopamine agonist, and the dose is gradually built up to the therapeutic range. Was this a good choice of medications? Six months later, the patient and his wife return for follow-up. It now becomes apparent that he is falling asleep at inappropriate times, such as at the dinner table, and when awake, he spends much of the time in arranging and"
        },
        {
            "id": "InternalMed_Harrison_3394",
            "title": "InternalMed_Harrison",
            "content": "By history, it is often difficult for patients to distinguish urinary frequency (often of small volumes) from true polyuria (>3 L/d), and a quantification of volume by 24-h urine collection may be needed (Fig. 61-4). Polyuria results from two potential mechanisms: excretion of nonabsorbable solutes (such as glucose) or excretion of water (usually from a defect in ADH production or renal responsiveness). To distinguish a solute diuresis from a water diuresis and to determine whether the diuresis is appropriate for the clinical circumstances, urine osmolality is measured. The average person excretes between 600 and 800 mosmol of solutes per day, primarily as urea and electrolytes. If the urine output is >3 L/d and the urine is dilute (<250 mosmol/L), total mosmol excretion is normal and a water diuresis is present. This circumstance could arise from polydipsia, inadequate secretion of vasopressin (central diabetes insipidus), or failure of renal tubules to respond to vasopressin"
        },
        {
            "id": "Pathoma_Husain_381",
            "title": "Pathoma_Husain",
            "content": "C. Clinical features are based on loss of free water. 1. Polyuria and polydipsia with risk oflife-threatening dehydration 2. 3. D. Water deprivation test fails to increase urine osmolality (useful for diagnosis). E. Treatment is desmopressin (ADH analog). III. NEPHROGENIC DIABETES INSIPIDUS A. Impaired renal response to ADH B. Due to inherited mutations or drugs (e.g., lithium and demeclocycline) C. Clinical features are similar to central diabetes insipidus, but there is no response to desmopressin. IV. SYNDROME OF INAPPROPRIATE ADH (SIADH) SECRETION A. Excessive ADH secretion B. Most often due to ectopic production (e.g., small cell carcinoma of the lung); other causes include CNS trauma, pulmonary infection, and drugs (e.g., cyclophosphamide). C. Clinical features are based on retention of free water. 1. 2. Mental status changes and seizures-Hyponatremia leads to neuronal swelling and cerebral edema. D. Treatment is free water restriction or demeclocycline."
        },
        {
            "id": "InternalMed_Harrison_3506",
            "title": "InternalMed_Harrison",
            "content": "of low volumes (<500 mL/d) of maximally concentrated urine, i.e., urine with osmolality >800 mOsm/kg; should this be the case, then an extrarenal source of water loss is primarily responsible for the generation of hypernatremia. Many patients with hypernatremia are polyuric; should an osmotic diuresis be responsible, with excessive excretion of Na+-Cl\u2013, glucose, and/or urea, then daily solute excretion will be >750\u20131000 mOsm/d (>15 mOsm/kg body water per day) (Fig. 63-6). More commonly, patients with hypernatremia and polyuria will have a predominant water diuresis, with excessive excretion of hypotonic, dilute urine. Adequate differentiation between nephrogenic and central causes of DI requires the measurement of the response in urinary osmolality to DDAVP, combined with measurement of circulating AVP in the setting of hypertonicity. By definition, patients with baseline hypernatremia are hypertonic, with an adequate stimulus for AVP by the posterior pituitary. Therefore, in contrast"
        },
        {
            "id": "InternalMed_Harrison_3400",
            "title": "InternalMed_Harrison",
            "content": "Formation of large volumes of dilute urine is usually due to polydipsic states or diabetes insipidus. Primary polydipsia can result from habit, psychiatric disorders, neurologic lesions, or medications. During deliberate polydipsia, extracellular fluid volume is normal or expanded and plasma vasopressin levels are reduced because serum osmolality tends to be near the lower limits of normal. Urine osmolality is also maximally dilute at 50 mosmol/L."
        },
        {
            "id": "InternalMed_Harrison_26604",
            "title": "InternalMed_Harrison",
            "content": "has severe pituitary DI or severe nephrogenic DI. However, this approach is of little or no diagnostic value if fluid deprivation results in concentration of the urine because the increases in urine osmolarity achieved both before and after the injection of desmopressin are similar in patients with partial pituitary DI,"
        },
        {
            "id": "InternalMed_Harrison_26590",
            "title": "InternalMed_Harrison",
            "content": "DIABETES INSIPIDUS Clinical Characteristics A decrease of 75% or more in the secretion or action of AVP usually results in DI, a syndrome characterized by the production of abnormally large volumes of dilute urine. The 24-h urine volume exceeds 50 mL/kg body weight, and the osmolarity is less than 300 mosmol/L. The polyuria produces symptoms of urinary frequency, enuresis, and/or nocturia, which may disturb sleep and cause mild daytime fatigue or somnolence. It also results in a slight rise in plasma osmolarity that stimulates thirst and a commensurate increase in fluid intake (polydipsia). Overt clinical signs of dehydration are uncommon unless thirst and/or the compensatory increase of fluid intake are also impaired."
        },
        {
            "id": "InternalMed_Harrison_3623",
            "title": "InternalMed_Harrison",
            "content": "The patient\u2019s water deprivation test was consistent with NDI, with an AVP level within the normal range in the setting of hypernatremia (i.e., no evidence of CDI) and an inappropriately low urine osmolality that failed to increase by >50% or >150 mOsm/kg after both water deprivation and the administration of DDAVP. This defect would be considered compatible with complete NDI; patients with partial NDI can achieve urine osmolalities of 500\u2013600 mOsm/kg after DDAVP treatment but will not maximally concentrate their urine to 800 mOsm/kg or higher."
        },
        {
            "id": "Neurology_Adams_4459",
            "title": "Neurology_Adams",
            "content": "As already stated, the usual cause of diabetes insipidus DI is a lack of vasopressin (ADH) secretion resulting from a lesion of the neurohypophysis. This leads to a reduction of absorption of water in the renal tubules. As a consequence, there is diuresis of low-osmolar urine, reduction in blood volume, and increased thirst and drinking of water (polydipsia) in an attempt to maintain osmolality. A congenital abnormality of renal tubular epithelium or destruction of the epithelium ultimately has a similar effect, but is termed nephrogenic DI. Notably, this type of DI may be provoked by lithium toxicity."
        },
        {
            "id": "InternalMed_Harrison_32077",
            "title": "InternalMed_Harrison",
            "content": "Laboratory assessment may be helpful in the differential diagnosis. Increased AGMA is most common in advanced methanol, ethylene glycol, and salicylate intoxication but can occur with any poisoning that results in hepatic, renal, or respiratory failure; seizures; or shock. The serum lactate concentration is more commonly low (less than the anion gap) in the former and high (nearly equal to the anion gap) in the latter. An abnormally low anion gap can be due to elevated blood levels of bromide, calcium, iodine, lithium, or magnesium. An increased osmolal gap\u2014a difference of >10 mmol/L between serum osmolality (measured by freezing-point depression) and osmolality calculated from serum sodium, glucose, and blood urea nitrogen levels\u2014 suggests the presence of a low-molecular-weight solute such as acetone; an alcohol (benzyl, ethanol, isopropanol, methanol); a glycol (diethylene, ethylene, propylene); ether (ethyl, glycol); or an \u201cunmeasured\u201d cation (calcium, magnesium) or sugar"
        },
        {
            "id": "Biochemistry_Lippincott_1323",
            "title": "Biochemistry_Lippinco",
            "content": "For Questions 27.7 and 27.8, use the following case. A sedentary 50-year-old man weighing 176 lb (80 kg) requests a physical. He denies any health problems. Routine blood analysis is unremarkable except for plasma total cholesterol of 295 mg/dl. (Reference value is <200 mg.) The man refuses drug therapy for his hypercholesterolemia. Analysis of a 1-day dietary recall showed the following: 7.4. Decreasing which one of the following dietary components would have the greatest effect in lowering the patient\u2019s plasma cholesterol? A. Carbohydrates B. Cholesterol C. Fiber D. Monounsaturated fat E. Polyunsaturated fat F. Saturated fat"
        },
        {
            "id": "Pathology_Robbins_4483",
            "title": "Pathology_Robbins",
            "content": "ADH deficiency causes diabetes insipidus, a condition characterized by excessive urination (polyuria) due to an inability of the kidney to resorb water properly from the urine. Diabetes insipidus can result from several causes, including head trauma, neoplasms, and inflammatory disorders of the hypothalamus and pituitary, and from surgical procedures involving the hypothalamus or pituitary. The condition sometimes arises spontaneously (idiopathic). Diabetes insipidus from ADH deficiency is designated central, to differentiate it from nephrogenic diabetes insipidus, which is caused by renal tubular unresponsiveness to circulating ADH. The clinical manifestations of both diseases are similar and include the excretion of large volumes of dilute urine with an inappropriately low specific gravity. Serum sodium and osmolality are increased as a result of excessive renal loss of free water, resulting in thirst and polydipsia. Patients who can drink water generally compensate for urinary"
        },
        {
            "id": "Histology_Ross_3533",
            "title": "Histology_Ross",
            "content": "the ADH is normal or elevated, but there is a lack of renal response to circulating levels of ADH. Nephrogenic diabetes is usually a congenital disorder re-lated to the mutation of the aquaporins-2 (AQP-2) water channels gene or different ADH V2 receptor mutations in kidney tubules. Hypothalamic diabetes insipidus is usu-ally treated by administration of synthetic analogs of ADH (desmopressin), whereas the treatment of the nephro-genic type of this disease is aimed at reducing the volume of urine output. Abnormally high levels of ADH are found in the syn-drome of inappropriate antidiuretic hormone secre-tion (SIADH), which is characterized by hyponatremia (low serum levels of sodium), decreased serum osmolality asso-ciated with excessive urine sodium excretion, and elevated urine osmolality. In SIADH, the elevated level of ADH in-creases the absorption of water, thereby leading to produc-tion of concentrated urine, inability to excrete water, and hyponatremia that results from excess"
        },
        {
            "id": "Pharmacology_Katzung_5601",
            "title": "Pharmacology_Katzung",
            "content": "A 65-year-old man undergoes cystoscopy because of the presence of microscopic hematuria in order to rule out urologic malignancy. The patient has mild dysuria and pyuria and empirically receives oral therapy with cip-rofloxacin for presumed urinary tract infection prior to the procedure and tolerates the procedure well. Approxi-mately 48 hours after the procedure, the patient presents to the emergency department with confusion, dysuria and chills. Physical exam reveals a blood pressure of 90/50, pulse of 120, temperature of 38.5\u00b0 C and respira-tory rate of 24. The patient is disoriented but the physical exam is otherwise unremarkable. Laboratory test shows WBC 24,000/mm3 and elevated serum lactate; urinalysis shows 300 WBC per high power field and 4+ bacteria. What possible organisms are likely to be responsible for the patient\u2019s symptoms? At this point, what antibiotic(s) would you choose for initial therapy of this potentially life-threatening infection?"
        },
        {
            "id": "InternalMed_Harrison_3685",
            "title": "InternalMed_Harrison",
            "content": "A stuporous 22-year-old man was admitted with a history of behaving strangely. His friends indicated he experienced recent emotional problems stemming from a failed relationship and had threatened suicide. There was a history of alcohol abuse, but his friends were unaware of recent alcohol consumption. The patient was obtunded on admission, with no evident focal neurologic deficits. The remainder of the physical examination was unremarkable. Na+ 140 meq/L K+ 5 meq/L Cl\u2212 95 meq/L HCO3\u2212 10 meq/L Glucose 125 mg/dL BUN 15 mg/dL Creatinine 0.9 mg/dL Ionized calcium 4.0 mg/dL Plasma osmolality 325 mOsm kg/H2O Urinalysis revealed crystalluria, with a mixture of envelope-shaped and needle-shaped crystals."
        },
        {
            "id": "Neurology_Adams_7069",
            "title": "Neurology_Adams",
            "content": "This condition is seen in the first hours after injury and may prove rapidly fatal. The CT scan shows enlargement of both hemispheres and compression of the basal cisterns and ventricles. There is usually no papilledema in the early stages, during which the child hyperventilates, vomits, and shows extensor posturing. The assumption has been that this represents a loss of regulation of cerebral blood flow and a massive increase in the blood volume of the brain. The administration of excessive water in intravenous fluids may contribute to the problem and should be avoided. Inappropriate secretion of antidiuretic hormone also exaggerates the swelling in some children. We have not observed this complication in adults. Fear of massive brain swelling from a second impact after a concussion has been raised as a rationale for keeping youngsters from returning to athletic activity, but there is only limited evidence for the existence of this entity in adults as noted by McCrory and Berkovic."
        },
        {
            "id": "InternalMed_Harrison_3649",
            "title": "InternalMed_Harrison",
            "content": "Creatinine (mg/dL) 1.2 2.35 2.10 2.02 1.97 1.79 1.53 1.20 1.13 days after DDAVP administration. It is 64e-6 conceivable that residual hypovolemic hyponatremia attenuated the recovery of the plasma Na+ concentration. Alternatively, attenuated recovery was due to persistent effects of the single dose of DDAVP. Of note, although the plasma half-life of DDAVP is only 1\u20132 h, pharmacodynamic studies indicate a much more prolonged effect on urine output and/or urine osmolality. One final consideration is the effect of the patient\u2019s initial renal dysfunction on the pharmacokinetics and pharmacodynamics of the administered DDAVP, which is renally excreted; DDAVP should be administered with caution for the reinduction of hyponatremia in patients with chronic kidney disease or acute renal dysfunction. A 44-year-old woman was referred from a local hospital after presenting with flaccid paralysis. Severe hypokalemia was documented (2.0 meq/L), and an infusion containing KCl was initiated."
        },
        {
            "id": "Pharmacology_Katzung_808",
            "title": "Pharmacology_Katzung",
            "content": "A 68-year-old man presents with a complaint of light-headedness on standing that is worse after meals and in hot environments. Symptoms started about 4 years ago and have slowly progressed to the point that he is disabled. He has fainted several times but always recovers conscious-ness almost as soon as he falls. Review of symptoms reveals slight worsening of constipation, urinary retention out of proportion to prostate size, and decreased sweating. He is otherwise healthy with no history of hypertension, diabetes, or Parkinson\u2019s disease. Because of urinary retention, he was placed on the \u03b11 antagonist tamsulosin, but the fainting spells got worse. Physical examination revealed a blood pres-sure of 167/84 mm Hg supine and 106/55 mm Hg standing. There was an inadequate compensatory increase in heart rate (from 84 to 88 bpm), considering the degree of ortho-static hypotension. Physical examination is otherwise unre-markable with no evidence of peripheral neuropathy or parkinsonian"
        },
        {
            "id": "Pharmacology_Katzung_3212",
            "title": "Pharmacology_Katzung",
            "content": "B. Decreased Thyroid Function Lithium probably decreases thyroid function in most patients exposed to the drug, but the effect is reversible or nonprogressive. Few patients develop frank thyroid enlargement, and fewer still show symptoms of hypothyroidism. Although initial thyroid testing followed by regular monitoring of thyroid function has been proposed, such procedures are not cost-effective. Obtaining a serum TSH concentration every 6\u201312 months, however, is prudent. C. Nephrogenic Diabetes Insipidus and Other Renal Adverse Effects Polydipsia and polyuria are common but reversible concomitants of lithium treatment, occurring at therapeutic serum concentrations. The principal physiologic lesion involved is loss of responsiveness to antidiuretic hormone (nephrogenic diabetes insipidus). Lithium-induced diabetes insipidus is resistant to vasopressin but responds to amiloride (see Chapter 15)."
        }
    ],
    "scores": [
        0.02626233352215094,
        0.025024060603807567,
        0.02469785575048733,
        0.023972313827747525,
        0.02216187587269488,
        0.020642300264644878,
        0.01985961633848958,
        0.019770657969415732,
        0.019049346879535557,
        0.01896117900790798,
        0.01890999910801891,
        0.018608274190756446,
        0.018068384378544806,
        0.01743396226415094,
        0.017116145271485077,
        0.017009009009009007,
        0.016946778711484593,
        0.016611524676040806,
        0.016584766584766583,
        0.016508152173913042,
        0.016461184121392768,
        0.016348592019217935,
        0.015417457305502846,
        0.015358455378201963,
        0.015332099051145569,
        0.015060080106809079,
        0.015027612574341546,
        0.014981483559645382,
        0.014829047196768155,
        0.014724310776942355,
        0.01472213847854487,
        0.014382645259938837
    ],
    "execution_time": 54.84996199607849
}